Mucha Artur, Lämmerhofer Michael, Lindner Wolfgang, Pawełczak Małgorzata, Kafarski Paweł
Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology, Wybrzeze Wyspiańskiego 27, 50-370 Wrocław, Poland.
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1550-4. doi: 10.1016/j.bmcl.2008.01.107. Epub 2008 Feb 2.
Individual stereoisomers of the phosphinic pseudodipeptide hPhepsi[P(O)(OH)CH(2)]Phe were obtained by stereoselective liquid chromatographic separation as N- and C-terminally protected derivative on quinidine carbamate modified silica stationary phase. The stereoisomeric purity, exceeding 95% for each fraction, was determined before and after deprotection using two independent methods. The absolute configuration was rationally assigned by application of enantiomerically pure phosphinic acid substrates in the synthetic procedure and correlation with biological activity of the products. Substantial differences in inhibition of leucine aminopeptidase by the individual isomers revealed novel insights into potency of the recently developed and remarkably effective compound.
膦酰基假二肽hPhepsi[P(O)(OH)CH(2)]Phe的各个立体异构体通过在氨基甲酸奎尼丁修饰的硅胶固定相上进行立体选择性液相色谱分离,得到N-和C-末端保护的衍生物。使用两种独立方法在脱保护前后测定了各馏分的立体异构纯度,均超过95%。通过在合成过程中应用对映体纯的膦酸底物并与产物的生物活性相关联,合理地确定了绝对构型。各个异构体对亮氨酸氨肽酶抑制作用的显著差异揭示了对这种最近开发的、非常有效的化合物效力的新见解。